These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2707412)

  • 1. [Effect of liposome-incorporated tubocurarine on the EEG of experimental animals].
    Aliautdin RN; Filippov VI
    Farmakol Toksikol; 1989; 52(1):20-3. PubMed ID: 2707412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
    Alyautdin RN; Tezikov EB; Ramge P; Kharkevich DA; Begley DJ; Kreuter J
    J Microencapsul; 1998; 15(1):67-74. PubMed ID: 9463808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppressive effect of GABA-containing liposomes on kindled convulsion].
    Mori N; Terayama K; Sato T; Kumashiro H
    No To Shinkei; 1989 Feb; 41(2):193-8. PubMed ID: 2736150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies.
    Xie Y; Ye L; Zhang X; Cui W; Lou J; Nagai T; Hou X
    J Control Release; 2005 Jun; 105(1-2):106-19. PubMed ID: 15893839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific changes in the defensive behavior of cats following injection of D-tubocurarine into the hypothalamic areas.
    Romaniuk A; Brudzyński S; Grońska J
    Acta Physiol Pol; 1973; 24(2):305-13. PubMed ID: 4740250
    [No Abstract]   [Full Text] [Related]  

  • 6. Technique of activation of experimental epileptic foci by using local disturbances of the blood-brain barrier.
    Revol M; Moene Y; Quoex C; Bello S
    Electroencephalogr Clin Neurophysiol; 1970 Jun; 28(6):647. PubMed ID: 4192861
    [No Abstract]   [Full Text] [Related]  

  • 7. [Technic of activating the experimental epileptic pathways using perturbations of the blood-brain barrier at the pathways' level].
    Revol M; Moene Y; Quoex C; Bello S
    Rev Neurol (Paris); 1969 Sep; 121(3):209-18. PubMed ID: 4908100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of cathionine (alpha-aminopropiophenone) on rat EEG activity].
    Berardelli A; Capocaccia L; Deodati M; Tancredi V; Quinteri F; Elmi AS
    Boll Soc Ital Biol Sper; 1980 Jun; 56(11):1122-6. PubMed ID: 7448018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metrizamide, iothalamate, and metrizoate: effects of internal carotid arterial injections on the blood-brain barrier of the rabbit.
    Rosenberg FJ; Romano JJ; Shaw DD
    Invest Radiol; 1980; 15(6 Suppl):S275-9. PubMed ID: 7203935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetrical changes in blood-brain barrier permeability during pentylenetetrazol-induced seizures and in acute hypertension.
    Oztaş B
    Psychiatry Res; 1998 May; 82(2):129-33. PubMed ID: 9754455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electroencephalographic manifestations of the convulsive reaction of rats to the intraventricular administration of quinolinic acid and kynurenine].
    Kozlovskiĭ VB; Prakh'e IV
    Farmakol Toksikol; 1988; 51(6):26-9. PubMed ID: 2976682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation, properties and therapeutic potential of cytidine diphosphocholine incorporated into liposomes].
    Burlina AP; Galzigna L
    Riv Neurol; 1989; 59(1):26-31. PubMed ID: 2762734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intraventricular curarimimetics on hippocampal electrical activity.
    Dajas F; Gaztelu JM; Zavalla CR; Macadar O; García-Austt E
    Exp Neurol; 1983 Jan; 79(1):160-7. PubMed ID: 6822252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
    Wu D; Pardridge WM
    J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on nerve growth factor liposomes on crossing blood-brain barrier in vitro and in vivo].
    Xie Y; Ye LY; Cui W; Xu K; Zhang XB; Lou JN; Hou XP
    Yao Xue Xue Bao; 2004 Nov; 39(11):944-8. PubMed ID: 15696939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive gene targeting to the brain.
    Shi N; Pardridge WM
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7567-72. PubMed ID: 10840060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.
    Neuwelt EA; Pagel M; Barnett P; Glassberg M; Frenkel EP
    Cancer Res; 1981 Nov; 41(11 Pt 1):4466-70. PubMed ID: 6796261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonneuronal origin of CO2-related DC EEG shifts: an in vivo study in the cat.
    Nita DA; Vanhatalo S; Lafortune FD; Voipio J; Kaila K; Amzica F
    J Neurophysiol; 2004 Aug; 92(2):1011-22. PubMed ID: 15056689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis.
    Boje KM
    Brain Res; 1996 May; 720(1-2):75-83. PubMed ID: 8782899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.